Rating History for Ovid Therapeutics Inc (OVID) by Roth/MKM
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/11/2025 | Boobalan Pachaiyappan | New Coverage | Buy (N/A) |
3.00 (N/A) |
1.57 (1.91) |
21.66% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/11/2025 | Boobalan Pachaiyappan | New Coverage | Buy (N/A) |
3.00 (N/A) |
1.57 (1.91) |
21.66% | Details |